Older Patients with Pancreatic Cancer Stage I-II in Belgium, Norway and the Netherlands from the EURECCA Pancreas Consortium

Background: There is lack of evidence on treatment and survival of older patients with pancreatic cancer. This is relevant since the population of older patients with pancreatic cancer is increasing and these patients are underrepresented in clinical trials. The aim of this study was to compare treatment strategies and survival outcomes of patients aged 70 years and older with pancreatic cancer stage I & II in three national cancer registries from the EURECCA Pancreas Consortium.